A summary of the ADVANCE Trial

Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S357-61. doi: 10.2337/dc09-S339.

Authors

Simon R Heller¹; ADVANCE Collaborative Group

Affiliation

¹ Academic Unit of Diabetes, Endocrinology and Metabolism, University of Sheffield Medical School, Sheffield, U.K. s.heller@sheffield.ac.uk

No abstract available

MeSH terms

Blood Glucose / drug effects
Blood Glucose / metabolism
Diabetes Mellitus, Type 2 / complications
Diabetes Mellitus, Type 2 / drug therapy
Diabetes Mellitus, Type 2 / therapy*
Diabetic Angiopathies / epidemiology
Diabetic Angiopathies / prevention & control
Diabetic Retinopathy / epidemiology
Disease Progression
Glycated Hemoglobin / drug effects
Glycated Hemoglobin / metabolism
Humans
Hypoglycemic Agents / therapeutic use
Insulin / therapeutic use
Metformin / therapeutic use*
Overweight / drug therapy
Randomized Controlled Trials as Topic
Risk Factors
Sulfonylurea Compounds / therapeutic use
Vascular Diseases / prevention & control

Substances

Blood Glucose
Glycated Hemoglobin A
Hypoglycemic Agents
Insulin
Sulfonylurea Compounds
Metformin